# Grace Therapeutics, Inc. (GRCE)

> Healthcare · US · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GRCE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -16.97M | $ -4.93M | $ 0 | $ 48.21M |
| 2025 | $ 0 | $ -6.94M | $ -10.13M | $ 0 | $ 64.89M |
| 2024 | $ 0 | $ -17.61M | $ -14.33M | $ 0 | $ 52.14M |
| 2023 | $ 0 | $ -54.24M | $ -14.09M | $ 24.0K | $ 64.68M |
| 2022 | $ 0 | $ -22.38M | $ -16.89M | $ 503.0K | $ 96.72M |
| 2021 | $ 207.0K | $ -19.68M | $ -19.51M | $ 22.0K | $ 111.06M |
| 2020 | $ 157.9K | $ -437.3K | $ -24.25M | $ 134.1K | $ 32.83M |
| 2019 | $ 0 | $ -66.50M | $ -34.23M | $ 1.51M | $ -4.77M |
| 2018 | $ 0 | $ -40.19M | $ -25.27M | $ 1.30M | $ 22.48M |
| 2017 | $ 0 | $ -13.32M | $ -8.44M | $ 1.24M | $ 12.11M |
| 2016 | $ 19.1K | $ -9.41M | $ -7.94M | $ 0 | $ 14.71M |
| 2015 | $ 193.2K | $ -6.81M | $ -7.43M | $ 0 | $ 21.71M |
| 2014 | $ 330.5K | $ -1.90M | $ -11.05M | $ 0 | $ 30.89M |
| 2013 | $ 418.9K | $ -13.88M | $ -2.70M | $ 0 | $ 19.34M |
| 2012 | $ 940.8K | $ -9.02M | $ -5.50M | $ 0 | $ 11.11M |
| 2011 | $ 155.8K | $ -8.14M | $ -6.24M | $ 0 | $ 13.09M |
| 2010 | $ 0 | $ -3.06M | $ -2.72M | $ 0 | $ -894.9K |
| 2009 | $ 0 | $ -1.55M | $ -2.29M | $ 0 | $ -3.31M |
| 2008 | $ 0 | $ -273.7K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.04 |
| Current Ratio | 11.47 |

## Other views

- [Metrics](https://sponda.capital/en/GRCE.md)
- [Charts](https://sponda.capital/en/GRCE/charts.md)
- [Compare](https://sponda.capital/en/GRCE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.